DFX Intelligence
Private Equity Intelligence
Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.
Transactions / Dallas Research Institute
SUMMIT CLINICAL RESEARCH SOLUTIONS EXPANDS PINNACLE SITE NETWORK WITH ACQUISITION OF DALLAS RESEARCH INSTITUTE
Add-on acquisitionclosedadd-onannounced Sep 10, 2026closed Sep 10, 2026Fact
What happened
- Platform
- Summit Clinical Research Solutionsadd-on basis: LongueVue Capital ("LVC") is pleased to announce that its portfolio company, Summit Clinical Research Solutions ("Summit" or the "Company"), an integrated clinical research organization designed to simplify sponsor engagement and accelerate trial execution across the clinical development lifecycle, has acquired Dallas Research Institute ("DRI") through its integrated site network, Pinnacle Clinical Research ("Pinnacle").
- Control
- Control
- Share acquired
- unknown
- Industry
- healthcare / clinic
- Target location
- unknown
- Seller kind
- unknown
- Rollover
- unknown
Values, only where disclosed
- Enterprise value
- Not disclosed
- Purchase price
- Not disclosed
- Equity value
- Not disclosed
- Target revenue
- Not disclosed
- Target EBITDA
- Not disclosed
- Multiple
- Not disclosed
Parties and roles
3 named
Buy side
- “LongueVue Capital ("LVC") is pleased to announce that its portfolio company, Summit Clinical Research Solutions ("Summit" or the "Company"), an integrated clinical research organization designed to simplify sponsor engagement and accelerate trial execution across the clinical development lifecycle, ”
- “LongueVue Capital ("LVC") is pleased to announce that its portfolio company, Summit Clinical Research Solutions ("Summit" or the "Company"), an integrated clinical research organization designed to simplify sponsor engagement and accelerate trial execution across the clinical development lifecycle, ”
Side not stated
- “LongueVue Capital ("LVC") is pleased to announce that its portfolio company, Summit Clinical Research Solutions ("Summit" or the "Company"), an integrated clinical research organization designed to simplify sponsor engagement and accelerate trial execution across the clinical development lifecycle, ”
Evidence
“LongueVue Capital ("LVC") is pleased to announce that its portfolio company, Summit Clinical Research Solutions ("Summit" or the "Company"), an integrated clinical research organization designed to simplify sponsor engagement and accelerate trial execution across the clinical development lifecycle, has acquired Dallas Research Institute ("DRI") through its integrated site network, Pinnacle Clinical Research ("Pinnacle").”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 15, 2026